Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Diabetes news

Show

From To
Diet and exercise advice lowers diabetes risk in people with HIV

Rates of diabetes are higher in people living with HIV than in the general population, but individualised lifestyle advice from a dietitian led to clinically and statistically

Published
26 March 2019
By
Roger Pebody
Integrase inhibitor treatment leads to greater weight gain

More evidence that HIV integrase inhibitor treatment is associated with weight gain, and that people gain more weight after beginning treatment with an integrase inhibitor than people

Published
07 March 2019
By
Keith Alcorn
Switching to Raltegravir or Dolutegravir Improves Leptin and Insulin in HIV

Switching to either raltegravir or dolutegravir from a ritonavir-boosted protease inhibitor during combination antiretroviral therapy (ART) has been associated with improved serum leptin levels and homeostasis model assessment of insulin resistance (HOMA) index scores in people with HIV infection, according to a study recently published in the Journal of Antimicrobial Chemotherapy.

Published
27 February 2019
From
Infectious Disease Advisor
As Waistlines Increase, Diabetes Sets In In Tanzania

Fast-changing lifestyle coupled with improving household economies have propelled the rate of obesity which culminates in diabetes at an alarming rate in Tanzania, with urban areas leading the tally. Medical experts say the metabolic disease is a looming health hazard in the country.

Published
16 January 2019
From
Health Policy Watch
High prevalence of diabetes and pre-diabetes in people at London HIV clinics

Around a third of people living with HIV receiving care at three large HIV clinics in south London had diabetes or pre-diabetes, while a Liverpool HIV clinic

Published
30 November 2018
By
Keith Alcorn
Treatment with modern antiretrovirals doesn't increase the risk of hypertension

There is no strong evidence that treatment with antiretrovirals significantly increases the risk of hypertension, investigators from the D:A:D study report in HIV Medicine. After taking into

Published
14 August 2018
By
Michael Carter
Diabetes isn't adequately managed in women with HIV, says US research

Optimum targets for control of type 2 diabetes are achieved in only 11% of women with HIV or at risk of HIV, according to US

Published
03 July 2018
By
Michael Carter
Rising Incidence of Diabetes in Adults With HIV on Antiretroviral Therapy

The burden of diabetes and prediabetes is rapidly increasing in people living with HIV on antiretroviral therapy (ART), according to research published in Epidemiology.

Published
27 March 2018
From
Infectious Disease Advisor
Long-Term Treated HIV No Defense Against Diabetes Risk

It has long been thought that the heightened risk of diabetes among people living with HIV was mostly due to early-generation antiretroviral drugs that raised glucose levels. But a longitudinal Australian study published in the Feb. 20, 2018, issue of AIDS found that, even in the modern treatment era, HIV-positive men who have sex with men (MSM) developed diabetes at an extremely high rate.

Published
06 March 2018
From
The Body Pro
US studies underline importance of primary care physicians for people with HIV

People with HIV who have other medical conditions such as high blood pressure or high lipids appear to do better if they have a primary

Published
01 March 2018
By
Keith Alcorn
← First12345...9Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.